GOSS (STOCKS)
Gossamer Bio, Inc. Common Stock
$2.380000
+0.030000 (+1.28%)
Prev close: $2.350000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Faheem Hasnain
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $536.98M
- Employees
- 145
- P/E (TTM)
- -3.38
- P/B (TTM)
- -6.52
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
9
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.21 | $-0.20 | -0.0144 | -7.36% |
|
Jun 2025 (Q2)
|
$-0.17 | $-0.18 | +0.0147 | +7.96% |
|
Mar 2025 (Q1)
|
$-0.16 | $-0.19 | +0.0313 | +16.36% |
|
Dec 2024 (Q4)
|
$-0.15 | $-0.17 | +0.0234 | +13.49% |
Financial Statements
| Revenues | $44.05M |
| Benefits Costs and Expenses | $202.62M |
| Costs And Expenses | $202.62M |
| Nonoperating Income/Loss | $2.25M |
| Operating Expenses | $204.87M |
| Operating Income/Loss | -$160.82M |
| Income/Loss From Continuing Operations After Tax | -$156.16M |
| Income/Loss From Continuing Operations Before Tax | -$158.57M |
| Income Tax Expense/Benefit | -$2.41M |
| Net Income/Loss | -$156.16M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$156.16M |
| Net Income/Loss Available To Common Stockholders, Basic | -$156.16M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.69 |
| Diluted Earnings Per Share | -$0.69 |
| Basic Average Shares | 455,155,786 |
| Diluted Average Shares | 455,155,786 |
| Assets | $208.82M |
| Current Assets | $203.99M |
| Noncurrent Assets | $4.83M |
| Fixed Assets | $70.00K |
| Other Non-current Assets | $4.76M |
| Liabilities | $291.15M |
| Current Liabilities | $62.12M |
| Accounts Payable | $1.12M |
| Wages | $11.97M |
| Other Current Liabilities | $49.03M |
| Noncurrent Liabilities | $229.04M |
| Equity | -$82.33M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$82.33M |
| Liabilities And Equity | $208.82M |
| Net Cash Flow From Operating Activities | -$158.43M |
| Net Cash Flow From Operating Activities, Continuing | -$158.43M |
| Net Cash Flow From Investing Activities | $136.42M |
| Net Cash Flow From Investing Activities, Continuing | $136.42M |
| Net Cash Flow From Financing Activities | $2.47M |
| Net Cash Flow From Financing Activities, Continuing | $2.47M |
| Net Cash Flow | -$19.55M |
| Net Cash Flow, Continuing | -$19.55M |
| Comprehensive Income/Loss | -$152.76M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$159.04M |
| Other Comprehensive Income/Loss | -$44.82M |
| Other Comprehensive Income/Loss Attributable To Parent | -$2.88M |